Functions of BRCA1 and RAD51 Paralogs in Genome Stability and Tumor Suppression via Homologous Recombination

NIH RePORTER · NIH · R01 · $365,619 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract The broad objective of this proposal is to understand the molecular mechanism of homologous recombination in humans, and to understand how the consequences of defects in recombinational DNA repair result in chromosomal instability and predisposition to cancers. Understanding the functions of key proteins in homologous recombination, many of which are tumor suppressors, will provide insight into how mutations in these proteins can predispose individuals to cancer. We plan to elucidate the biochemical roles and examine the mechanism of BRCA1, BLM, EXO1, PALB2, WRN, and the RAD51 paralogs (RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3) functions, as well as the consequences of the interactions between these proteins, to provide insight into their role in recombinational DNA repair. We plan to reconstitute the initial steps of human recombinational DNA repair, focusing on the DNA resection step, and thereby understand the biochemical functions of these proteins. In addition, we will use single-molecule technologies to reveal the molecular mechanisms by which these proteins act.

Key facts

NIH application ID
10565421
Project number
1R01CA276290-01
Recipient
UNIVERSITY OF CALIFORNIA AT DAVIS
Principal Investigator
Stephen Charles Kowalczykowski
Activity code
R01
Funding institute
NIH
Fiscal year
2023
Award amount
$365,619
Award type
1
Project period
2023-03-01 → 2028-02-29